# NDR Medical Technology Pte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ndr-medical-technology-pte

- Industry: Medical Devices & Equipment
- Headquarters: Singapore, Singapore
- Website: www.ndrmedical.com
- Total disclosed funding: $6.5M
- Latest round: Series B (Mar 24, 2021)
- Investors on record: 5

## About

NDR Medical Technology Pte Ltd develops advanced AI-empowered interventional robotics, focusing on enhancing precision in minimally invasive medical procedures through innovative technology.Founded in 2015 and based in Singapore, NDR Medical Technology Pte Ltd specializes in interventional robotics. The company has undergone no known pivots or changes in strategy since its inception. NDR Medical Technology raised USD 0.37 mn in Series B funding on March 24, 2021, from ST Engineering Ventures, bringing its total capital raised to USD 0.37 mn. The company is currently valued at USD 7.907 mn. The CEO, Alan Goh, leads the organization with a vision for innovation in medical technology.NDR Medical Technology specializes in advanced AI-empowered interventional robotics, with flagship products including the Automated Needle Targeting (ANT) systems, namely ANT-C and ANT-X. These systems enhance the precision of needle placement in interventional radiology and urology procedures. The ANT-C system automates lesion detection and needle path planning using CT-scan images, while ANT-X integrates C-arm fluoroscopy with AI software for accurate needle placement. Their offerings target hospitals and medical institutions globally, including regions such as Singapore and Japan.NDR Medical Technology reported revenue of USD 7,933.60 mn for the year 2023, with an EBITDA of USD -591,713.50. The company generates revenue through B2B transactions, where healthcare providers purchase its robotic systems and subscribe to ongoing support and software updates. Revenue is derived from sales of the ANT systems coupled with maintenance and training services for effective implementation in clinical settings.NDR Medical Technology plans to leverage its recent Series B funding of USD 0.37 mn to expand its product line and market reach. The company aims to launch new iterations of its ANT systems designed to further enhance minimally invasive surgical procedures within the next year. Additionally, it targets expansion into emerging markets in Southeast Asia and Japan by 2025, enhancing its partnerships with medical institutions to drive adoption of its technologies.

## Funding rounds

- Series B, Mar 24, 2021, $0.4M — ST Engineering Ventures
- Series B, Jul 23, 2020, $6.2M — Microport Scientific Corporation, SGInnovate, Kava Labs Inc., NTUitive

## Investors

- Microport Scientific Corporation — Series B
- SGInnovate (https://capitalatlas.ai/funds/sginnovate) — Series B
- Kava Labs Inc. — Series B
- NTUitive (https://capitalatlas.ai/funds/ntuitive) — Series B
- ST Engineering Ventures (https://capitalatlas.ai/funds/st-engineering-ventures) — Series B